249 / 1631
Time [months]
4xABVD
2xABVD
Overall Survival
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0
12
24
36
48
60
72
84
96
108
120
5y-FFTF difference 0,5%
95% CI [-2,6%; 1,6%]
p=0,92
Engert et al; NEJM 2010
GHSG HD10 Clinical Trial
Overall Survival